---
category: news
title: "Kiromic BioPharma Significantly Expands Gamma Delta T cell Product Pipeline with New Sponsored Research Agreement"
excerpt: "Kiromic BioPharma, Inc. (NASDAQ: KRBP), a clinical-stage biotherapeutics company using its proprietary DIAMOND Â® artificial intelligence (AI) and data mining platform to discover and develop cell and gene therapies with a focus on immuno-oncology,"
publishedDateTime: 2022-06-07T11:06:00Z
originalUrl: "https://apnews.com/press-release/business-wire/science-technology-health-artificial-intelligence-ab2d5dea652b439cb161f326146ac999"
webUrl: "https://apnews.com/press-release/business-wire/science-technology-health-artificial-intelligence-ab2d5dea652b439cb161f326146ac999"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Healthcare
  - AI

secured: "3f8210w9apFwvvNj+a98L54TbakIws4+2OLBFKozSK8n+t/mIEtLpx1ZMIlCG8MuRy/JJPQ+o1m76YQsd0WQAgHMFJTPnuNSG4TpjBzLUt76FuC+4HxT1es3ce0Ukf/j8QliZJNwH3nsata88e1GG2CS34XTwupd7XONGsxHfr/P2dw97kNoFxOYAYrMebQ5WQe7Dyx6l8F1L9S6Ox1KtycrjAvPSs9ww/sPSp46OEjHwFMWZwSFWjmAzOlxFQqxAVfbQSwpV5RfZcFS98CfRf0g+wZ7ltVuWMO6ovRpBMewLxJ6/7YpQig9j6VEGV2vFO1Kje1LOocFqUpgG/2iPOPvxkREWJhGGrVEJXJzlq0=;dvDdPCQmPxJ6Upu6E+O9ZQ=="
---

